Prof. Meinrad Beer

Prof. Dr. Meinrad Beer, Director of the Clinic for Diagnostic and Interventional Radiology, University Hospital Ulm

02/2022

Prof. Meinrad Beer

mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.

Related Resources

Pancreas staging in clinical routine at University Hospital Innsbruck - Interview with PD Dr. Widmann

10/2018

The University Hospital in Innsbruck, Austria, has been using mint Lesion™ since mid-2015 with the initial focus on clinical trials in order to…

Assessment time halved: Importance of a good tumor response assessment tool in clinical site reads

09/2018

The Clinical Research Imaging Core (CRIC) of the University of Wisconsin Carbone Cancer Center (UWCCC) recently published a poster at the AACI CRI…

Study - free text reporting vs. mint Lesion in clinical routine

02/2018

Free text reporting in the tumor response assessment of radiologic imaging data is common in clinical routine, whereas in clinical trials standardized…

Name	Purpose	Lifetime	Type	Provider
CookieConsent	Saves your consent to using cookies.	1 year	HTML	Website
fe_typo_user	Assigns your browser to a session on the server.	session	HTTP	Website

Name	Purpose	Lifetime	Type	Provider
_pk_id	Used to store a few details about the user such as the unique visitor ID.	13 months	HTML	Matomo
_pk_ref	Used to store the attribution information, the referrer initially used to visit the website.	6 months	HTML	Matomo
_pk_ses	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_cvar	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_hsr	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo

Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.